Diversified Enterprises’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$750K Sell
31,160
-19,524
-39% -$511K 0.04% 198
2026
Q1
$1.42M Buy
50,684
+2,190
+5% +$58.3K 0.08% 115
2025
Q4
$1.21M Buy
48,494
+22,794
+89% +$575K 0.07% 110
2025
Q3
$655K Buy
25,700
+1,178
+5% +$29.1K 0.04% 133
2025
Q2
$594K Buy
24,522
+1,306
+6% +$30.5K 0.04% 142
2025
Q1
$588K Buy
23,216
+2,200
+10% +$57.6K 0.05% 145
2024
Q4
$558K Sell
21,016
-3,086
-13% -$83.7K 0.05% 118
2024
Q3
$698K Buy
+24,102
New +$703K 0.08% 98

Other funds holding PFE

Diversified Enterprises's PFE Position: Q2 2026 in Review

Diversified Enterprises reduced its Pfizer (PFE) stake by 39% in Q2 2026, selling an estimated $511K and leaving 31,160 shares worth $750K. The position accounts for 0.04% of the portfolio, ranked #198.

Diversified Enterprises first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.42M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Diversified Enterprises held 31,160 shares of Pfizer worth $750K as of Q2 2026.
  • Diversified Enterprises sold 19,524 Pfizer shares in Q2 2026, an estimated $511K.
  • Pfizer made up 0.04% of Diversified Enterprises's portfolio in Q2 2026, its #198 holding.
  • Diversified Enterprises first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • Diversified Enterprises's Pfizer position peaked at $1.42M in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.